GNSRX Mutual Fund

GNSRX Mutual Fund (Abrdn US Small Cap Equity Fund Class R) is managed by Aberdeen with $3.6M in net assets. GNSRX expense ratio is 1.60%, holding 58 positions across sectors including Financials, Health Care, Industrials. Inception date: 2003-12-30.

GNSRX performance shows a YTD return of 14.52%. The 1-year return is 17.68% and the 5-year return is 3.58%.

GNSRX top holdings include Ligand Pharmaceuticals, Inc. (2.9%), Q2 Holdings, Inc. (2.8%), Kiniksa Pharmaceuticals Inte (2.8%), Magnolia Oil & Gas Corp (2.8%), Wintrust Financial Corp (2.7%). Go to all GNSRX holdings, GNSRX sectors, or GNSRX dividends.

GNSRX can be compared against other funds. Use GNSRX overlap to find shared positions, or GNSRX vs another fund for a side-by-side view. GNSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.